CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Cash flows from operating activities:
Net income (loss)	$ (22.0)	$ 17.3
Depreciation and amortization	17.0	18.3
Benefit plan expense greater (less) than cash funding	1.5	(0.8)
Deferred income taxes	(9.4)	(1.0)
Distributions from (contributions to) Ti02 manufacturing joint venture, net	(0.8)	11.2
Contract related intangible asset impairment	5.1
Other, net	(1.6)	3.3
Change in assets and liabilities:
Accounts and other receivables, net	(17.5)	(50.5)
Inventories, net	20.1	(8.8)
Land held for development, net	(1.0)	2.0
Accounts payable and accrued liabilities	(10.6)	(30.8)
Accounts with affiliates	(15.6)	13.5
Income taxes	(3.5)	(1.8)
Other, net	4.9	(2.1)
Net cash used in operating activities	(33.4)	(30.2)
Cash flows from investing activities:
Capital expenditures	(16.4)	(13.3)
Capitalized permit costs	(0.8)	(0.1)
Purchases of marketable securities	(1.5)	(5.2)
Disposals of marketable securities	2.1	7.2
Change in restricted cash equivalents, net	(0.9)	(0.2)
Other, net	0.2
Net cash used in investing activities	(17.3)	(11.6)
Indebtedness:
Borrowings	30.9	19.2
Principal payments	(11.3)	(14.9)
Valhi cash dividends paid	(6.8)	(6.8)
Distributions to noncontrolling interest in subsidiaries	(3.5)	(3.8)
Net cash provided by (used in) financing activities	9.3	(6.3)
Cash and cash equivalents – net change from:
Operating, investing and financing activities	(41.4)	(48.1)
Effect of exchange rate on cash	1.3	(8.2)
Cash and cash equivalents at beginning of period	202.3	255.8
Cash and cash equivalents at end of period	162.2	199.5
Cash paid for:
Interest, net of capitalized interest	14.9	14.2
Income taxes, net	3.7	9.1
Noncash investing activities:
Change in accruals for capital expenditures	$ 2.3	$ 1.8